5T4-Targeted Therapy Ablates Cancer Stem Cells and Prevents Recurrence of Head and Neck Squamous Cell Carcinoma.
about
Therapeutic antibodies against cancer stem cells: a promising approach.Trends in Surgical Research in Head and Neck Cancer.Cancer stem cells as targets for immunotherapy.A novel 5T4-targeting antibody-drug conjugate H6-DM4 exhibits potent therapeutic efficacy in gastrointestinal tumor xenograft models.
P2860
5T4-Targeted Therapy Ablates Cancer Stem Cells and Prevents Recurrence of Head and Neck Squamous Cell Carcinoma.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
5T4-Targeted Therapy Ablates C ...... Neck Squamous Cell Carcinoma.
@en
5T4-Targeted Therapy Ablates C ...... Neck Squamous Cell Carcinoma.
@nl
type
label
5T4-Targeted Therapy Ablates C ...... Neck Squamous Cell Carcinoma.
@en
5T4-Targeted Therapy Ablates C ...... Neck Squamous Cell Carcinoma.
@nl
prefLabel
5T4-Targeted Therapy Ablates C ...... Neck Squamous Cell Carcinoma.
@en
5T4-Targeted Therapy Ablates C ...... Neck Squamous Cell Carcinoma.
@nl
P2093
P2860
P50
P1476
5T4-Targeted Therapy Ablates C ...... d Neck Squamous Cell Carcinoma
@en
P2093
David A Tice
Elaine M Hurt
Felipe Nör
Jacques E Nör
Kelsey A Finkel
Kristy A Warner
Max S Wicha
Robert E Hollingsworth
Samuel A Kerk
Zhaocheng Zhang
P2860
P304
P356
10.1158/1078-0432.CCR-16-1834
P407
P577
2016-10-25T00:00:00Z